ARTICLE | Company News
Baxter Healthcare Corp. blood products/substitutes news
September 21, 1998 7:00 AM UTC
Baxter discontinued all development of its HemAssist crosslinked hemoglobin blood substitute and will focus development efforts on second-generation genetically engineered hemoglobin molecules being d...